Jane Street’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Jane Street’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,073	Closed	-$580K	–	7836
2020 Q1	$580K	Buy	+12,073	New	+$562K	﹤0.01%	3466
2019 Q4	–	Sell	-9,909	Closed	-$234K	–	6110
2019 Q3	$234K	Buy	+9,909	New	+$294K	﹤0.01%	4461

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Jane Street's RARX Position: Q2 2020 in Review

Jane Street sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 12,073 shares — an estimated $580K sold.

Jane Street first reported a position in RARX in Q3 2019 and held it in 2 quarters. The position peaked at $580K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Jane Street reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Jane Street sold 12,073 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $580K.
Jane Street first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
Jane Street's Ra Pharmaceuticals, Inc. Common Stock position peaked at $580K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Jane Street's 13F filing for Q2 2020, filed 17 Aug 2020.